67 results
Page 2 of 4
424B5
dkrean
21 Oct 21
Prospectus supplement for primary offering
4:26pm
8-K
EX-1.1
fzeenqt
21 Oct 21
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:24pm
424B5
u1r10g5x
20 Oct 21
Prospectus supplement for primary offering
4:15pm
8-K
ndnyl 3mg7
2 Sep 21
Crinetics Pharmaceuticals Expands Executive Team with Addition of Jeff Knight as Chief Operating Officer
5:00pm
8-K
EX-99.1
t2u2ws1 24oc
2 Sep 21
Crinetics Pharmaceuticals Expands Executive Team with Addition of Jeff Knight as Chief Operating Officer
5:00pm
S-3ASR
EX-4.4
rqhrs y5frw
10 Aug 21
Automatic shelf registration
5:25pm
S-3ASR
740qs13tluch37
10 Aug 21
Automatic shelf registration
5:25pm
8-K
EX-99.1
d2ubabx6bwpyic3dnku5
29 Jul 21
Stock Purchase Agreement
4:15pm
8-K
EX-1.1
qbat74a5bwod5fb
8 Apr 21
Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
4:09pm
424B5
js04 eo0kisbj9moi
8 Apr 21
Prospectus supplement for primary offering
4:07pm
8-K
EX-99.1
hbw6n7dlhhg6dp x0c
3 Sep 20
Crinetics Pharmaceuticals Appoints Rare Disease Executive, Camille L. Bedrosian, M.D., to Board of Directors
7:35am
424B5
tpp15 nsacz
15 Apr 20
Prospectus supplement for primary offering
4:16pm
8-K
EX-1.1
3wxc8 0x26jur
15 Apr 20
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:06pm
424B5
r4p2b 5yrkf047
14 Apr 20
Prospectus supplement for primary offering
4:49pm
S-3/A
cq0jychs07a21c93b
19 Aug 19
Shelf registration (amended)
4:17pm